Parkinson's Disease
Lancet 363:1783-1793, Samii,A.,et al, 2004
Fatal Myositis Due to the Microsporidian Brachiola algerae, a Mosquito Pathogen
NEJM 351:42-47, Coyle,C.M.,et al, 2004
Vacuum Cleaner Epilepsy
Neurol 63:190-191, Carlson,C. &St. Louis,E.K., 2004
Management of Myasthenia Gravis
Semin Neurol 24:41-48, Saperstein,D.S. &Barohn,R.J., 2004
Diffusion-Weighted MRI Abnormalities as an Early Diagnostic Marker for Creutzfeldt-Jakob Disease
Neurol 63:443-449,410, Shiga,Y.,et al, 2004
Clinical Implications of Benign Multiple Sclerosis: A 20-Year Population-Based Follow-Up Study
Ann Neurol 56:303-306, Pittock,S.J.,et al, 2004
Neurologic Manifestations in Primary Sjogren Syndrome: A Study of 82 Patients
Medicine 83:280-291, Delalande,S.,et al, 2004
Strokes in the Subinsular Territory
Neurol 63:2429-2432, Kumral,E.,et al, 2004
Severe Tacrolimus Leukoencephalopathy After Liver Transplantation
AJNR 24:2085-2088, Schuuring,J.,et al, 2003
The Neurosurgical Treatment of Pain
Arch Neurol 60:1537-1540, Giller,C.A., 2003
Diffusion-Weighted Magnetic Resonance Imaging and Identification of the Epileptogenic Tuber in Patients with Tuberous Sclerosis
Arch Neurol 60:1580-1584, Jansen,F.E.,et al, 2003
The Impact of Delays in Computed Tomography of the Brain on the Accuracy of Diagnosis and Subsequent Management in Patients with Minor Stroke
JNNP 74:77-81, Wardlaw,J.M.,et al, 2003
Treatment of Refractory Myasthenia: "Rebooting" with High-Dose Cyclophosphamide
Ann Neurol 53:29-34,7, Drachman,D.B.,et al, 2003
An Organic Cause of Neuropsychiatric Illness in Adolescence
Lancet 361:572, Taylor,S.E.,et al, 2003
Interferons in Relapsing Remitting Multiple Sclerosis: A Systematic Review
Lancet 361:545-552, Filippini,G.,et al, 2003
Bilateral Striatal Necrosis Associated with Mycoplasma pneumoniae Infection
NEJM 348:720, van Vuiren,M. &Uhl,M., 2003
Practice Parameter: Evaluation of the Child with Global Developmental Delay
Neurol 60:367-380, Shevell,M.,et al, 2003
Transmission of West Nile Virus from an Organ Donor to Four Transplant Recipients
NEJM 348:2196-2203, Iwamoto,M.,et al, 2003
Clinicopath Conf., West Nile Virus Meningoencephalitis
NEJM 348:2239-2247, Case17-2003, 2003
Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003
Recent Advnaces in the Treatment of Epilepsy
Arch Neurol 60:929-935, Nguyen,D.K. &Spencer,S.S., 2003
Lupus and Zoster
Lancet 362:616, Douglas,K.M.J., 2003
Emergent EEG, Indications and Diagnostic Yield
Neurol 61:702-704, Varelas,P.N.,et al, 2003
Practice Parameter:Immunotherapy for Guillain-Barre Syndrome, Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurol 61:736-740, Hughes,R.A.C.,et al, 2003
Prognosis of Patients with Suspected Primary CNS Angiitis and Negative Brain Biopsy
Neurol 61:831-833, Alreshaid,A.A.&Powers,W.J., 2003
Self Reported Stressful Life Events and Exacerbations in Multiple Sclerosis:Prospective Study
BMJ 327:646-649, Beljevac,D.,et al, 2003
Polymyositis and Dermatomyositis
Lancet 362:971-982, Dalakas,M.C.&Hohlfeld,R., 2003
Five-Year Follow-up of Bilateral Stimulatioin of the Subthalamic Nucleus in Advanced Parkinson's Disease
NEJM 349:1925-1934,1888, Krack,P.,et al, 2003
Clinical Importance of Neutralising Antibodies Against Interferon Beta in Patients with Relapsing-Remitting Multiple Sclerosis
Lancet 362:1184-1191, Sorensen,P.S.,et al, 2003
Voltage-Gated Potassium Channel Antibodies in Limbic Encephalitis
Ann Neurol 54:530-533, Pozo-Rosich,P.,et al, 2003
Treatment of Autoimmune Myasthenia Gravis
Neurol 61:1652-1661, Richman,D.P. & Agius,M.A., 2003
Association of Ischemic Lesion Patterns on Early Diffusion-Weighted Imaging with TOAST Stroke Subtypes
Arch Neurol 60:1730-1734, Kang,D.,et al, 2003
Treatments of Parkinson Disease
Arch Neurol 60:1680-1684, Shults,C.W., 2003
Long-Term Follow-Up of Thalamic Deep Brain Stimulation for Essential and Parkinsonian Tremor
Neurol 61:1601-1604, Kumar,R.,et al, 2003
The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis
Neurol 61:1332-1338, Goodin,D.S.,et al, 2003
Stroke Location, Characterization, Severity, and Outcome in Mitral vs Aortic Valve Endocarditis
Neurol 61:1341-1346, Anderson,D.J.,et al, 2003
Isolated Shoulder Paresis Caused by a Small Cortical Infarction
Neurol 61:1457, Komatsu,K.,et al, 2003
Neuropsychological and Quality of Life Outcomes 12 Months After Unilateral Thalamic Stimulation for Essential Tremor
JNNP 74:305-311, Fields,J.A.,et al, 2003
Bilateral Vertebral Artery Occlusion Resulting from Giant Cell Arteritis: Report of 3 Cases and Review of the Literature
Medicine 82:1-12, Ruegg,S.,et al, 2003
Peri-ictal Water Drinking Lateralizes Seizure Onset to the Nondominant Temporal Lobe
Neurol 60:873-876, Trinka,E.,et al, 2003
Treatment of Wilson Disease With Ammonium Tetrathiomolybdate, III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy
Arch Neurol 60:379-385, Brewer,G.J.,et al, 2003
POEMS Syndrome Associated with Ischemic Stroke
Arch Neurol 60:745-749, Kang, K.,et al, 2003
Reappraisal of Early CT signs to Predict the Arterial Occlusion Site in Acute Embolic Stroke
JNNP 74:649-653, Koga,M.,et al, 2003
West Nile Encephalitis
BMJ 326:865-869, Solomon,T.,et al, 2003
Pure Dysarthria Due to Small Cortical Stroke
Neurol 60:1178-1180, Kim,J.S.,et al, 2003
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003
Antivonvulsants for Creutzfeldt-Jakob Disease?
Lancet 361:224, Fioel,A.,et al, 2003
Non-convulsive Status Epilepticus: Usefulness of Clinical Features in Selecting Patients for Urgent EEG
JNNP 74:189-191, Husain,A.M.,et al, 2003
Cerebral Toxoplasmosis Following Etanercept Treatment for Idiophatic Pneumonia Syndrome after Autologous Peripheral Blood Progenitor Cell Transplantation (PBPCT)
Ann Hematol 82:649-653, Gonzalez-Vicent, M.,et al, 2003
Cortical Laminar Necrosis in Brain Infarcts: Serial MRI
Neuroradiology 45:283-288, Siskas, N.,et al, 2003